Bioshield II Legislation Published
The Bioshield II (S.975) legislation first proposed by Sen. Lieberman on April 27th was published online today and may be read here:
Bioshield-II
I might have some more to say about the legislation in an upcoming newsletter. Suffice for now to say that, if passed, the wildcard patent extension is just huge for large pharma, as they can reap two years of peak sales with no additional R&D investment. That could mean billions heading right for the bottom line. Stay tuned to the debates on this one.
Sen. Lieberman’s press release on the bill is here:
Press-Release
A nice UPI piece on the legislation’s compromises was written by Dee Ann Divis:
UPI-Story
Finally, have a look at what the Generic Pharma Industry has to say about the bill:
Generic-Pharma-Industry
